Sclerosteosis
Sclerosteosis is a rare genetic disorder characterized by abnormal bone growth. It is caused by mutations in the SOST gene, which is involved in the regulation of bone formation. The condition is primarily found in the Afrikaner population of South Africa, where it has a prevalence of about 1 in 100,000.
Symptoms and Signs[edit]
The symptoms of sclerosteosis typically become apparent in early childhood. They include:
- Facial distortion due to overgrowth of the skull and jaw bones
- Hearing loss caused by the overgrowth of bones in the ear
- Increased bone density (sclerosis), particularly in the skull and long bones
- Tall stature due to overgrowth of the long bones
- Hand abnormalities such as large hands and fingers
- Foot abnormalities such as large feet and toes
Causes[edit]
Sclerosteosis is caused by mutations in the SOST gene, which is located on chromosome 17. This gene provides instructions for making a protein that regulates bone formation. Mutations in the SOST gene lead to an overproduction of bone, resulting in the symptoms of sclerosteosis.
Diagnosis[edit]
The diagnosis of sclerosteosis is typically based on the characteristic physical features and confirmed by genetic testing. Imaging studies such as X-rays and CT scans can also be used to assess the extent of bone overgrowth.
Treatment[edit]
There is currently no cure for sclerosteosis. Treatment is aimed at managing the symptoms and may include surgery to relieve pressure on the brain and nerves caused by bone overgrowth.
See also[edit]
- Van Buchem disease, a related condition caused by a different mutation in the SOST gene
- Osteopetrosis, a group of conditions characterized by increased bone density
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
